Increased responsiveness and decreased expression of G proteins in deoxycorticosterone hypertension

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 740-745

  Kanagy, Nancy L ^a   Webb, R Clinton ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

aluminum fluoride; G proteins; mineralocorticoids

Indexed keywords

ALUMINUM FLUORIDE; DEOXYCORTICOSTERONE; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; THORACIC AORTA;

EID: 9044247073     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.740     Document Type: Conference Paper

References (30)

1. Wilson SK. Peripheral alpha-1 and alpha-2 adrenergic receptors in three models of hypertension in rats: an in vitro autoradiography study. J Pharmacol Exp Ther. 1991;256:801-810.
2. Birnbaumer L, Birnbaumer M. Signal transduction by G proteins: 1994 edition. J Recept Sig Trans Res. 1995;15:213-252.
3. Taylor SJ, Chae HZ, Rhee SG, Exton JH. Activation of the beta-1 isozyme of phospholipase C by alpha-suhunit of Gq class of G proteins. Nature. 1991;350:516-518.
4. Dickerson CD, Weiss ER. The coupling of pertussis toxin-sensitive G proteins to phospholipase A, and adenylyl cyclase in CHO cells expressing bovine rhodopsin. Exp Cell Res. 1995;216:46-50.
5. Dolphin AC. Voltage-dependent calcium channels and their modulation by neurotransmitters and G proteins. Exp Physiol. 1995;80: 1-36.
6. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995; 268:C799-C822.
7. Onali P, Olianas MC. Bimodal regulation of cyclic AMP by muscarinic receptors: involvement of multiple G proteins and different forms of adenylyl cyclase. Life Sci. 1995;56:973-980.
8. Matsumoto H, Baron CB, Coburn RF. Smooth muscle stretch-activated phospholipase C activity. Am J Physiol. 1995;268:C458-C465.
9. Raymond JR. Multiple mechanisms of receptor-G protein signaling specificity. Am J Physiol. 1995;269:F141-F158. Editorial.
10. Anand-Srivastava MB, de Champlain J, Thibault C. DOCA-salt hypertensive rat hearts exhibit altered expression of G proteins. Am J Hypertens. 1993;6:72-75.
11. iα in cardiac hypertrophy due to acquired hypertension. Hypertension. 1992:20:103-112.
12. Anand-Srivastava MB. Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats: relationship to adenylate cyclase inhibition. Biochem J. 1992;288: 79-85.
13. Li P, Zou AP, al-Kayed NJ, Rusch NJ, Harder DR. Guanine nucleotide-binding proteins in aortic smooth muscle from hypertensive rats. Hypertension. 1994;23:914-918.
14. Clark CJ, Milligan G, Connell JM. Guanine nucleotide regulatory protein alterations in young Milan hypertensive strain rats. Biochim Biophys Acta. 1994;1225:149-157.
15. Mecca TE, Webb RC. Vascular responses to serotonin in steroid hypertensive rats. Hypertension. 1984;6:887-892.
16. Bigay J, Deterre P, Pfister C, Chabre M. Fluoroaluminates activate transducin-GDP by mimicking the gamma-phosphate of GTP in its binding site. FEBS Lett. 1985;191:181-185.
17. Higashijima T, Burnier J, Ross EM. Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. J Biol Chem. 1990;265:14176-14186.
18. Walenga R, Vanderhoek JY, Feinstein MB. Serine esterase inhibitors block stimulus-induced mobilization of arachidonic acid and phosphatidylinositide-specific phospholipasc C activity in platelets. J Biol Chem. 1980;255:6024-6027.
19. Mahadevappa VG, Sicilia F. Mobilization of arachidonic acid in thrombin-stimulated human platelets. Biochem Cell Biol. 1990;68: 520-527.
20. Davies MG, Ramkumar V, Gettys TW, Hagen P-O. The expression and function of G-proteins in experimental intimal hyperplasia. J Clin Invest. 1994;94:1680-1689.
21. Nürnberg B, Gudermann T, Schultz G. Receptors and G proteins as primary components of transmembrane signal transduction, part 2. G proteins: structure and function. J Mol Med. 1995;73:123-132.
22. Holloway ET, Bohr DF. Reactivity of vascular smooth muscle in hypertensive rats. Circ Res. 1973;33:678-685.
23. Stanton HC. Experimental hypertension. In: Schwartz A, ed. Methods in Pharmacology. New York, NY: Plenum Press; 1971: 125-150.
24. Bruner CA, Mangiapane ML, Fink GD, Webb RC. Area postrema ablation and vascular reactivity in deoxycorticosterone-salt-treated rats. Hypertension. 1988;11:668-673.
25. Suzuki S, Takata Y, Kubota S, Ozaki S, Kato H. Characterization of the alpha-1 adrenoceptors in the mesenteric vasculature from deoxycorticosterone-salt hypertensive rats: studies on vasoconstriction, radioligand binding and postreceptor events. J Pharmacol Exp Ther. 1994;268:576-583.
26. 2+ efflux in arteries from deoxycorticosterone acetate hypertensive rats. Hypertension. 1992;19:734-738.
27. r=38,000 phosphoprotein phosphatase: modulation by divalent cations, ATP, and fluoride. J Biol Chem. 1983;258:4214-4219.
28. Shetty KT, Guru V, Guru SC. Phosphatase activity against neurofilament proteins from bovine spinal cord: effect of aluminum and neuropsychoactive drugs. Neurosci Lett. 1992;137:83-86.
29. + currents in guinea pig chromaffin cells. J Gen Physiol. 1995;105: 249-266.
30. Uehara Y, Numabe A, Ishimitsu T, Ishii M, Yagi S. Role of cardiovascular phospholipase A2 and C in the development of DOCA-salt hypertensive rats. Adv Exp Med Biol. 1989;247(A): 231-236.